Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Cefaclor 375mg modified-release tablets |
| BNF code | 0501021A0AAAGAG |
| Virtual Therapeutic Moiety | Cefaclor |
| Date identifier became valid | 5 Nov 2018 |
| Previous product identifier | 323803009 |
| Basis of preferred name | pINN - Proposed International Non-proprietary Name |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Cefaclor monohydrate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 387270009 |
| Strength value numerator | 375.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tabletmodified-release.oral |
| Dose Form | |
| Formulation | Modified-release tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Distaclor MR 375mg tablets (Flynn Pharma Ltd) | |
| Virtual Medicinal Product Packs | |
| Cefaclor 375mg modified-release tablets 14 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.